E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedReviewed
Evidence for prescribing exercise as therapy in chronic disease.
Pedersen, B K, Saltin, B · Scandinavian journal of medicine & science in sports · 2006 · DOI
Quick Summary
This review examined whether exercise therapy helps treat many different diseases, including chronic fatigue syndrome (ME/CFS). The authors looked at evidence showing how exercise affects disease causes, symptoms, fitness, and quality of life across multiple conditions. They also discussed how much exercise is safe and effective for each disease.
Why It Matters
For ME/CFS patients and researchers, this review is important because it positions ME/CFS alongside other chronic diseases in the exercise therapy literature and provides a framework for evaluating exercise's role in disease management. However, this broad-spectrum approach may not adequately address ME/CFS-specific challenges, particularly post-exertional malaise (PEM), which distinguishes ME/CFS from most other chronic diseases reviewed.
Observed Findings
- Exercise therapy shows therapeutic effects across metabolic syndrome-related disorders, cardiovascular and pulmonary diseases, and select musculoskeletal conditions.
- Fibromyalgia and chronic fatigue syndrome are discussed as conditions where exercise therapy may have a role.
- Exercise effects vary by disease type, with different mechanisms operating in metabolic versus inflammatory versus musculoskeletal conditions.
- Quality of life improvements are reported across multiple disease categories with exercise intervention.
Inferred Conclusions
- Exercise therapy is an effective treatment modality across numerous chronic diseases with distinct pathophysiologies.
- Prescription principles for exercise must be individualized based on disease type and patient status.
- Exercise produces benefits through multiple mechanisms including improved metabolic function, cardiovascular adaptation, and immune modulation.
Remaining Questions
- What are the specific mechanisms by which exercise benefits ME/CFS patients, and how do these differ from mechanisms in other fatiguing conditions?
- How should exercise prescription be modified for ME/CFS patients who experience post-exertional malaise?
- What defines the threshold between therapeutic and harmful exercise intensity in ME/CFS?
What This Study Does Not Prove
This review does not prove that standard exercise prescriptions used for other chronic diseases are appropriate for ME/CFS. It does not differentiate between diseases where exercise is universally beneficial and those (like ME/CFS) where exercise may be harmful for some patients. The inclusion of ME/CFS alongside conditions with different pathophysiology does not establish that mechanisms of exercise benefit are comparable.
Tags
Symptom:Fatigue
Method Flag:Weak Case Definition
Metadata
- DOI
- 10.1111/j.1600-0838.2006.00520.x
- PMID
- 16451303
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.